Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Prime Medicine Inc's Business Segments
Prime Medicine Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q1 FY2026
Reportable Segments
1
Largest Segment
Reportable
Total Revenue
$ 1
Regions Reported
-
Revenue Share by Reportable Segment - Q1 FY2026
- Reportable100%
Revenue by Reportable Segment - Q1 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Reportable | $ 1 | 100% |
Description of Prime Medicine Inc
Prime Medicine Inc is a biotechnology company that focuses on the development of cutting-edge therapies for genetic diseases through the use of gene editing technologies. The company was founded in and is headquartered in .
Prime Medicine's main goal is to provide innovative treatments for patients with genetic disorders by correcting and modifying the underlying genetic mutations responsible for these conditions. Their approach involves leveraging CRISPR-based gene editing tools combined with advanced delivery technologies to directly edit the patient's genome.
One of the key strengths of Prime Medicine is their highly skilled and multidisciplinary team of scientists, engineers, and clinicians, who work together to drive advancements in gene editing technologies. The company places a strong emphasis on collaboration and partnerships, working closely with academic institutions, research organizations, and industry leaders to accelerate the development of their therapies.
Prime Medicine's pipeline includes a range of gene editing programs targeting different genetic diseases, such as cystic fibrosis, sickle cell anemia, muscular dystrophy, and various types of cancer. They have developed unique strategies to address the challenges associated with specific disease types, including efficient delivery systems and precise targeting technologies.
The company's approach to gene editing is highly precise, aiming to correct genetic mutations at the DNA level to permanently address the root causes of genetic diseases. This approach has the potential to revolutionize the treatment landscape and offer significant therapeutic benefits to patients with currently incurable genetic disorders.
Prime Medicine takes a patient-centered approach in their research and development efforts. They prioritize the safety and efficacy of their therapies, conducting extensive preclinical and clinical studies to ensure that their treatments meet the highest quality standards. The company is committed to obtaining regulatory approvals and making their therapies accessible to patients worldwide.
In addition to their gene editing programs, Prime Medicine invests in research and development of novel technologies to enhance the precision, efficiency, and delivery of their gene editing tools. This commitment to innovation positions them as a leading player in the field of gene therapy.
In summary, Prime Medicine Inc is a biotechnology company focused on revolutionizing the treatment of genetic diseases through the development of advanced gene editing therapies. With a strong scientific foundation, a robust pipeline, and a patient-centered approach, Prime Medicine is poised to make a significant impact on the future of genetic medicine.
Prime Medicine's main goal is to provide innovative treatments for patients with genetic disorders by correcting and modifying the underlying genetic mutations responsible for these conditions. Their approach involves leveraging CRISPR-based gene editing tools combined with advanced delivery technologies to directly edit the patient's genome.
One of the key strengths of Prime Medicine is their highly skilled and multidisciplinary team of scientists, engineers, and clinicians, who work together to drive advancements in gene editing technologies. The company places a strong emphasis on collaboration and partnerships, working closely with academic institutions, research organizations, and industry leaders to accelerate the development of their therapies.
Prime Medicine's pipeline includes a range of gene editing programs targeting different genetic diseases, such as cystic fibrosis, sickle cell anemia, muscular dystrophy, and various types of cancer. They have developed unique strategies to address the challenges associated with specific disease types, including efficient delivery systems and precise targeting technologies.
The company's approach to gene editing is highly precise, aiming to correct genetic mutations at the DNA level to permanently address the root causes of genetic diseases. This approach has the potential to revolutionize the treatment landscape and offer significant therapeutic benefits to patients with currently incurable genetic disorders.
Prime Medicine takes a patient-centered approach in their research and development efforts. They prioritize the safety and efficacy of their therapies, conducting extensive preclinical and clinical studies to ensure that their treatments meet the highest quality standards. The company is committed to obtaining regulatory approvals and making their therapies accessible to patients worldwide.
In addition to their gene editing programs, Prime Medicine invests in research and development of novel technologies to enhance the precision, efficiency, and delivery of their gene editing tools. This commitment to innovation positions them as a leading player in the field of gene therapy.
In summary, Prime Medicine Inc is a biotechnology company focused on revolutionizing the treatment of genetic diseases through the development of advanced gene editing therapies. With a strong scientific foundation, a robust pipeline, and a patient-centered approach, Prime Medicine is poised to make a significant impact on the future of genetic medicine.
Prime Medicine Inc is at the forefront of genetic medicine, leveraging advanced technologies and innovative approaches to address a variety of diseases and medical conditions. Their operations encompass several key segments, products, and services designed to harness the potential of gene therapy and gene editing. Below is an extensive overview of these components:
1. Segments:
a. Genetic Medicine
Prime Medicine operates within the genetic medicine segment, focusing on therapeutic interventions that directly target genetic material to treat diseases. This specialization includes developing strategies that involve the correction of genetic defects, enabling the possibility of curing hereditary conditions that have long posed challenges in the medical field.
b. Gene Editing
The company has a significant emphasis on gene editing technologies, which allow for precise modifications of specific genes. Utilizing advanced tools such as CRISPR-Cas9 and other innovative platforms, Prime Medicine can implement targeted changes within the genome, offering potential solutions for a range of genetic disorders.
Products and Services:
a. Gene Therapy
At the core of Prime Medicines offerings are gene therapies designed to replace or supplement defective genes responsible for various genetic disorders. These therapies work by delivering functional copies of genes into affected cells, restoring normal cellular function and alleviating disease symptoms. This approach is particularly transformative for patients with inherited conditions, allowing them to potentially achieve better health outcomes.
b. Gene Editing Tools
In addition to therapeutic products, Prime Medicine provides cutting-edge gene editing tools to researchers and pharmaceutical companies. These tools encompass proprietary gene editing systems, including advanced delivery vehicles, nucleases, and other molecular components critical for the precise modification of genes. By making these resources available, Prime Medicine supports the broader scientific community in advancing genetic research.
c. Platform Development
Prime Medicine engages in platform development services, creating innovative technologies and systems aimed at enhancing gene editing efficiency, precision, and safety. This effort seeks to refine current methodologies and develop new approaches that can improve the overall gene editing process, thus contributing to more effective therapeutic solutions.
d. Disease-specific Programs
The company has established dedicated research programs that target specific diseases such as neurodegenerative disorders, inherited genetic diseases, cancers, and rare diseases. Each program is tailored to address the unique characteristics and challenges of the respective conditions, fostering a focused research and development approach.
e. Preclinical and Clinical Testing
Prime Medicine undertakes extensive preclinical and clinical testing of their gene therapies and gene editing technologies. This rigorous evaluation process assesses the safety and efficacy of their products in animal models and human subjects, ensuring that new treatments meet the stringent standards necessary for regulatory approval and clinical application.
Key Focus Areas:
a. Precision Medicine
Prime Medicine envisions a future with accessible precision medicine tailored to individual patients. Their research prioritizes personalized treatments, integrating patient-specific genetic data into therapeutic strategies. This approach is crucial for optimizing treatment efficacy and minimizing adverse effects.
b. Therapeutic Advancements
The company is committed to advancing genetic medicine through continuous innovation. Their research team explores novel strategies, including groundbreaking delivery methods, next-generation gene editing techniques, and the engineering of more effective genetic constructs, all aimed at enhancing therapeutic outcomes.
c. Collaboration and Partnerships
Prime Medicine actively seeks collaborations with academic institutions, pharmaceutical companies, and research organizations to expedite the development and commercialization of genetic therapies. By pooling expertise from various domains, the company aims to address complex challenges and facilitate the delivery of groundbreaking treatments to patients.
Summary
In conclusion, Prime Medicine Inc is dedicated to pushing the boundaries of genetic medicine and gene editing. Through its specialized segments, comprehensive product and service offerings, and a commitment to innovation and collaboration, the company aims to deliver transformative genetic therapies that address pressing medical needs and improve patient outcomes across a spectrum of diseases.
1. Segments:
a. Genetic Medicine
Prime Medicine operates within the genetic medicine segment, focusing on therapeutic interventions that directly target genetic material to treat diseases. This specialization includes developing strategies that involve the correction of genetic defects, enabling the possibility of curing hereditary conditions that have long posed challenges in the medical field.
b. Gene Editing
The company has a significant emphasis on gene editing technologies, which allow for precise modifications of specific genes. Utilizing advanced tools such as CRISPR-Cas9 and other innovative platforms, Prime Medicine can implement targeted changes within the genome, offering potential solutions for a range of genetic disorders.
Products and Services:
a. Gene Therapy
At the core of Prime Medicines offerings are gene therapies designed to replace or supplement defective genes responsible for various genetic disorders. These therapies work by delivering functional copies of genes into affected cells, restoring normal cellular function and alleviating disease symptoms. This approach is particularly transformative for patients with inherited conditions, allowing them to potentially achieve better health outcomes.
b. Gene Editing Tools
In addition to therapeutic products, Prime Medicine provides cutting-edge gene editing tools to researchers and pharmaceutical companies. These tools encompass proprietary gene editing systems, including advanced delivery vehicles, nucleases, and other molecular components critical for the precise modification of genes. By making these resources available, Prime Medicine supports the broader scientific community in advancing genetic research.
c. Platform Development
Prime Medicine engages in platform development services, creating innovative technologies and systems aimed at enhancing gene editing efficiency, precision, and safety. This effort seeks to refine current methodologies and develop new approaches that can improve the overall gene editing process, thus contributing to more effective therapeutic solutions.
d. Disease-specific Programs
The company has established dedicated research programs that target specific diseases such as neurodegenerative disorders, inherited genetic diseases, cancers, and rare diseases. Each program is tailored to address the unique characteristics and challenges of the respective conditions, fostering a focused research and development approach.
e. Preclinical and Clinical Testing
Prime Medicine undertakes extensive preclinical and clinical testing of their gene therapies and gene editing technologies. This rigorous evaluation process assesses the safety and efficacy of their products in animal models and human subjects, ensuring that new treatments meet the stringent standards necessary for regulatory approval and clinical application.
Key Focus Areas:
a. Precision Medicine
Prime Medicine envisions a future with accessible precision medicine tailored to individual patients. Their research prioritizes personalized treatments, integrating patient-specific genetic data into therapeutic strategies. This approach is crucial for optimizing treatment efficacy and minimizing adverse effects.
b. Therapeutic Advancements
The company is committed to advancing genetic medicine through continuous innovation. Their research team explores novel strategies, including groundbreaking delivery methods, next-generation gene editing techniques, and the engineering of more effective genetic constructs, all aimed at enhancing therapeutic outcomes.
c. Collaboration and Partnerships
Prime Medicine actively seeks collaborations with academic institutions, pharmaceutical companies, and research organizations to expedite the development and commercialization of genetic therapies. By pooling expertise from various domains, the company aims to address complex challenges and facilitate the delivery of groundbreaking treatments to patients.
Summary
In conclusion, Prime Medicine Inc is dedicated to pushing the boundaries of genetic medicine and gene editing. Through its specialized segments, comprehensive product and service offerings, and a commitment to innovation and collaboration, the company aims to deliver transformative genetic therapies that address pressing medical needs and improve patient outcomes across a spectrum of diseases.